Zacks Research Issues Negative Forecast for Avantor Earnings

Avantor, Inc. (NYSE:AVTR) – Equities researchers at Zacks Research decreased their FY2025 earnings per share estimates for shares of Avantor in a research note issued to investors on Wednesday, November 19th. Zacks Research analyst Team now anticipates that the company will post earnings per share of $0.91 for the year, down from their previous estimate of $0.96. The consensus estimate for Avantor’s current full-year earnings is $1.06 per share. Zacks Research also issued estimates for Avantor’s Q4 2025 earnings at $0.22 EPS, Q1 2026 earnings at $0.20 EPS, Q2 2026 earnings at $0.23 EPS, Q3 2026 earnings at $0.23 EPS, Q4 2026 earnings at $0.23 EPS, FY2026 earnings at $0.89 EPS, Q1 2027 earnings at $0.22 EPS, Q2 2027 earnings at $0.21 EPS and FY2027 earnings at $1.00 EPS.

A number of other research analysts have also recently weighed in on the stock. Royal Bank Of Canada reduced their price target on shares of Avantor from $20.00 to $17.00 and set an “outperform” rating on the stock in a research report on Monday, August 4th. Wells Fargo & Company reduced their target price on shares of Avantor from $19.00 to $16.00 and set an “overweight” rating on the stock in a report on Monday, August 4th. Barclays reiterated an “equal weight” rating and issued a $12.00 price target (down from $15.00) on shares of Avantor in a report on Thursday, October 30th. Morgan Stanley reduced their price objective on Avantor from $15.00 to $12.00 and set an “equal weight” rating on the stock in a research note on Monday, August 4th. Finally, JPMorgan Chase & Co. reaffirmed a “neutral” rating and issued a $12.00 target price (down previously from $14.00) on shares of Avantor in a research report on Thursday, October 30th. Four research analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the company’s stock. Based on data from MarketBeat, Avantor currently has a consensus rating of “Hold” and a consensus target price of $14.42.

Avantor Stock Down 0.2%

Shares of NYSE:AVTR opened at $10.99 on Friday. The company has a debt-to-equity ratio of 0.65, a quick ratio of 0.96 and a current ratio of 1.49. Avantor has a 1 year low of $10.82 and a 1 year high of $23.32. The stock has a market capitalization of $7.49 billion, a P/E ratio of -84.50, a PEG ratio of 3.79 and a beta of 1.00. The stock has a 50-day simple moving average of $12.83 and a 200-day simple moving average of $13.00.

Avantor (NYSE:AVTR) last announced its quarterly earnings results on Wednesday, October 29th. The company reported $0.22 EPS for the quarter, missing the consensus estimate of $0.23 by ($0.01). The firm had revenue of $1.62 billion for the quarter, compared to analyst estimates of $1.65 billion. Avantor had a positive return on equity of 10.91% and a negative net margin of 1.25%.The business’s revenue was down 5.3% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.26 earnings per share. Avantor has set its FY 2025 guidance at 0.880-0.920 EPS.

Institutional Inflows and Outflows

Institutional investors have recently modified their holdings of the business. Voss Capital LP grew its stake in Avantor by 905.6% during the 3rd quarter. Voss Capital LP now owns 4,525,000 shares of the company’s stock valued at $56,472,000 after purchasing an additional 4,075,000 shares in the last quarter. Coldstream Capital Management Inc. purchased a new position in shares of Avantor during the 3rd quarter valued at approximately $172,000. Danica Pension Livsforsikringsaktieselskab acquired a new stake in shares of Avantor during the third quarter worth approximately $787,000. Danske Bank A S bought a new stake in shares of Avantor in the third quarter worth $85,000. Finally, Caitong International Asset Management Co. Ltd raised its holdings in Avantor by 217.9% in the third quarter. Caitong International Asset Management Co. Ltd now owns 14,682 shares of the company’s stock valued at $183,000 after acquiring an additional 10,063 shares in the last quarter. Institutional investors and hedge funds own 95.08% of the company’s stock.

Insider Buying and Selling

In other news, Director Gregory L. Summe acquired 100,000 shares of the firm’s stock in a transaction on Thursday, October 30th. The stock was bought at an average cost of $11.25 per share, with a total value of $1,125,000.00. Following the transaction, the director directly owned 300,000 shares in the company, valued at approximately $3,375,000. This represents a 50.00% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this link. 1.20% of the stock is owned by corporate insiders.

Avantor Company Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.